NCT04707612
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +2 more
- Locations
-
- Shenzhen Center for Chronic Disease Control Shenzhen, Guangdong, China
Clinical trial condition
Dyslipidemias
Explore clinical trials studying Dyslipidemias. Study availability and eligibility vary by location and protocol.
279 public trials
34 recruiting studies
Dyslipidemias trial results
NCT04074551
- Conditions
- Cardiovascular Diseases, Dyslipidemias, Hypertension, +4 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT02489331
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Daesung Medical Center Bucheon-si, South Korea
- Isam Clinic Busan, South Korea
- DongRae BongSeng Hospital Busan, South Korea
- Hyundai Medical Clinic Daegu, South Korea
NCT03557476
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +2 more
- Locations
-
- University of Nebraska at Omaha Omaha, Nebraska, United States
NCT03415503
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Department of Nutrition and Food Hygiene,School of Public Health, Sun Yat-sen University Guangzhou, Guangdong, China
NCT04014686
- Conditions
- Behavior, Cardiovascular Diseases, Dyslipidemias, +10 more
- Locations
-
- The University of Nebraska at Omaha Omaha, Nebraska, United States
NCT03856476
- Conditions
- Children, Only, Dyslipidemias, Endothelial Dysfunction, +12 more
- Locations
-
- University of Ioannina Ioannina, Greece
NCT04186780
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- University of Sorocaba Sorocaba, São Paulo, Brazil
Completed
Effects of Pitavastatin Treatments on the Plasma Lgi3 Level in the Patients With Dyslipidemia
NCT03730038
- Conditions
- Dyslipidemias, Lipid Metabolism Disorders, Metabolic Diseases, +1 more
- Locations
-
- Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine Seoul, South Korea
Completed
Effect of HMG-CoA Reductase Inhibitors on the Meibomian Gland Morphology in Patients With Meibomitis
NCT04085016
- Conditions
- Blepharitis, Dyslipidemias, Eye Diseases, +6 more
- Locations
-
- National Taiwan University Hospital Taipei, Taiwan